Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Tommaso D'Antuono"'
Autor:
Graziano De Luca, Chiara Di Lisio, Giuseppe Lattanzio, Tommaso D’Antuono, Marcella Liberatore, Francesca Bianca Aiello
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-5 (2018)
Abstract Background In immunocompetent patients, acute toxoplasmosis is usually asymptomatic. We identified M1 macrophages in a case of symptomatic acute Toxoplasma gondii infection that resolved without treatment. M1 macrophages have been demonstrat
Externí odkaz:
https://doaj.org/article/949054af29cd4d42a2c1711a8a96d346
Autor:
Antonio Marchetti, Franco Cuccurullo, Sandra Rosini, Roberta Zappacosta, Tommaso D'Antuono, Irene Centi, Patrizia Viola, Sara Malatesta, Alessia Di Lorito, Giampaolo Filice, Maela Del Grammastro, Lara Felicioni, Fiamma Buttitta
Purpose: The therapeutic choice for patients with lung adenocarcinoma depends on the presence of EGF receptor (EGFR) mutations. In many cases, only cytologic samples are available for molecular diagnosis. Bronchoalveolar lavage (BAL) and pleural flui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a76f9c32f47243e7907e278f3283c7
https://doi.org/10.1158/1078-0432.c.6522467
https://doi.org/10.1158/1078-0432.c.6522467
Autor:
Antonio Marchetti, Franco Cuccurullo, Sandra Rosini, Roberta Zappacosta, Tommaso D'Antuono, Irene Centi, Patrizia Viola, Sara Malatesta, Alessia Di Lorito, Giampaolo Filice, Maela Del Grammastro, Lara Felicioni, Fiamma Buttitta
PDF file - 99K,List of forward and reverse fusion primers utilized for PCR amplification of EGFR exon 19 and 21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::250a203e2557d710fd8822ba4aa1fd3b
https://doi.org/10.1158/1078-0432.22452398.v1
https://doi.org/10.1158/1078-0432.22452398.v1
Autor:
Filippo de Marinis, Fiamma Buttitta, Graziano De Luca, Andrea Vingiani, Lara Felicioni, Giampaolo Filice, Antonio Passaro, Tommaso D'Antuono, Felice Mucilli, Antonio Marchetti, Lucio Crinò, Marcella Liberatore, Chiara Di Lisio, Elena Guerini-Rocco, Luigi Guetti, Maria Vittoria Pace, Luciana Irtelli, Massimo Barberis, Alessia Di Lorito
Publikováno v:
JCO Precision Oncology. :1-9
Purpose Crizotinib, a mesenchymal-epithelial transition/anaplastic lymphoma kinase/c-ros oncogene 1 (ROS1) inhibitor, has recently been approved by the US Food and Drug Administration for the treatment of patients with advanced ROS1-positive non–sm
Autor:
Felice Mucilli, Alessia Di Lorito, Antonio Marchetti, Lara Felicioni, Maria Vittoria Pace, Giampaolo Filice, Tommaso D'Antuono, Marcella Liberatore, Sara Canarecci, Fiamma Buttitta, Luigi Guetti
Publikováno v:
Lung Cancer. 99:11-16
Objectives Anaplastic Lymphoma Kinase (ALK) gene rearrangements have been described in 3–5% of lung adenocarcinomas (ADC) and their identification is essential to select patients for treatment with ALK tyrosine kinase inhibitors. For several years,
Autor:
Tommaso D'Antuono, Alessia Di Lorito, Fiamma Buttitta, Luigi Guetti, Felice Mucilli, Lara Felicioni, Manuela Iezzi, Antonio Marchetti, Maria Vittoria Pace, Giampaolo Filice
Publikováno v:
Journal of Thoracic Oncology. 11(4):487-495
Introduction Recent regulatory changes have allowed the diagnostic use of immunohistochemical (IHC) analysis for the identification of patients with non–small cell lung cancer who are eligible for treatment with anaplastic lymphoma receptor tyrosin
Autor:
Mauro Papotti, Giorgio V. Scagliotti, Renato Franco, Luisella Righi, Graziano De Luca, Stefania Staibano, Tommaso D'Antuono, Gaetano De Rosa, Massimo Barberis, Fiamma Buttitta, Marco Volante, Maria Vittoria Pace, Carmine Pinto, Antonio Marchetti, Elena Guerini-Rocco
Introduction Among the several agents targeting the programmed cell death 1 (PD-1) pathway, pembrolizumab is currently the only one approved for the treatment of patients with NSCLC in association with a companion diagnostic assay, the anti–PD-L1 i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31c0196999d564febaad7c7f5b14eb74
http://hdl.handle.net/11588/697492
http://hdl.handle.net/11588/697492
Autor:
Maela Del Grammastro, Patrizia Viola, Sandra Rosini, Lara Felicioni, Franco Cuccurullo, Alessia Di Lorito, Tommaso D'Antuono, Antonio Marchetti, Giampaolo Filice, Fiamma Buttitta, Irene Centi, Sara Malatesta, Roberta Zappacosta
Publikováno v:
Clinical Cancer Research. 19:691-698
Purpose: The therapeutic choice for patients with lung adenocarcinoma depends on the presence of EGF receptor (EGFR) mutations. In many cases, only cytologic samples are available for molecular diagnosis. Bronchoalveolar lavage (BAL) and pleural flui
Autor:
Patrizia Viola, Lucia Centurione, Franco O. Ranelletti, Giuseppe Lattanzio, Roberta Di Pietro, Francesca B. Aiello, Marcella Liberatore, Tommaso D'Antuono, Paolo Felaco, Mario Bonomini
Publikováno v:
Translational Medicine Communications. 1
IgA nephropathy (IgAN) exhibits a variable course ranging from a benign condition to progressive renal failure with a high proportion of patients undergoing end-stage renal disease in the long term. It is unclear how to predict the risk of this progr
Autor:
Marcello Piccirilli, E. Di Carlo, C Di Iorio, A Scarinci, Tommaso D'Antuono, M Pasquale, M. Di Nicola, Carlo Sorrentino
Publikováno v:
The Journal of Pathology. 209:400-410
Heart allograft outcome is unpredictable and acute rejection episodes still occur despite the improvement of immunosuppressive regimens. We therefore investigated whether the immunopathological profile of endomyocardial biopsies might underlie the va